CTW CAYMAN-CL A (CTW) Fundamental Analysis & Valuation

NASDAQ:CTWKYG2589A1058

Current stock price

2.33 USD
-0.04 (-1.69%)
Last:

This CTW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CTW Profitability Analysis

1.1 Basic Checks

  • In the past year CTW was profitable.
  • In the past year CTW had a positive cash flow from operations.
CTW Yearly Net Income VS EBIT VS OCF VS FCFCTW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 2M 4M 6M

1.2 Ratios

  • CTW's Return On Assets of 8.23% is amongst the best of the industry. CTW outperforms 87.34% of its industry peers.
  • The Return On Equity of CTW (13.85%) is better than 88.61% of its industry peers.
Industry RankSector Rank
ROA 8.23%
ROE 13.85%
ROIC N/A
ROA(3y)10.24%
ROA(5y)N/A
ROE(3y)18.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTW Yearly ROA, ROE, ROICCTW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • With a decent Profit Margin value of 4.24%, CTW is doing good in the industry, outperforming 72.15% of the companies in the same industry.
  • CTW has a Gross Margin of 76.15%. This is amongst the best in the industry. CTW outperforms 83.54% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 4.24%
GM 76.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTW Yearly Profit, Operating, Gross MarginsCTW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 20 40 60

5

2. CTW Health Analysis

2.1 Basic Checks

  • CTW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CTW remains at a similar level compared to 1 year ago.
  • CTW has a worse debt/assets ratio than last year.
CTW Yearly Shares OutstandingCTW Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 20M 40M 60M
CTW Yearly Total Debt VS Total AssetsCTW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • CTW has an Altman-Z score of 7.84. This indicates that CTW is financially healthy and has little risk of bankruptcy at the moment.
  • CTW has a Altman-Z score of 7.84. This is amongst the best in the industry. CTW outperforms 96.20% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CTW is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, CTW is in the better half of the industry, outperforming 72.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.84
ROIC/WACCN/A
WACC6.81%
CTW Yearly LT Debt VS Equity VS FCFCTW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 5M 10M 15M 20M 25M

2.3 Liquidity

  • CTW has a Current Ratio of 2.15. This indicates that CTW is financially healthy and has no problem in meeting its short term obligations.
  • CTW's Current ratio of 2.15 is fine compared to the rest of the industry. CTW outperforms 77.22% of its industry peers.
  • CTW has a Quick Ratio of 2.15. This indicates that CTW is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CTW (2.15) is better than 78.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
CTW Yearly Current Assets VS Current LiabilitesCTW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 5M 10M 15M

1

3. CTW Growth Analysis

3.1 Past

  • The earnings per share for CTW have decreased strongly by -35.93% in the last year.
  • Looking at the last year, CTW shows a very strong growth in Revenue. The Revenue has grown by 32.07%.
EPS 1Y (TTM)-35.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.93%
Revenue 1Y (TTM)32.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTW Yearly Revenue VS EstimatesCTW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 20M 40M 60M 80M

1

4. CTW Valuation Analysis

4.1 Price/Earnings Ratio

  • CTW is valuated quite expensively with a Price/Earnings ratio of 38.83.
  • Based on the Price/Earnings ratio, CTW is valued a bit cheaper than 74.68% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CTW to the average of the S&P500 Index (26.17), we can say CTW is valued slightly more expensively.
Industry RankSector Rank
PE 38.83
Fwd PE N/A
CTW Price Earnings VS Forward Price EarningsCTW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 64.88
CTW Per share dataCTW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CTW Dividend Analysis

5.1 Amount

  • No dividends for CTW!.
Industry RankSector Rank
Dividend Yield 0%

CTW Fundamentals: All Metrics, Ratios and Statistics

CTW CAYMAN-CL A

NASDAQ:CTW (4/6/2026, 3:33:00 PM)

2.33

-0.04 (-1.69%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.03%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap145.39M
Revenue(TTM)90.37M
Net Income(TTM)3.83M
AnalystsN/A
Price TargetN/A
Short Float %2.12%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.83
Fwd PE N/A
P/S 1.61
P/FCF N/A
P/OCF 1305.13
P/B 5.26
P/tB 5.26
EV/EBITDA 64.88
EPS(TTM)0.06
EY2.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFY0.08%
SpS1.45
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.77
Profitability
Industry RankSector Rank
ROA 8.23%
ROE 13.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.24%
GM 76.15%
FCFM N/A
ROA(3y)10.24%
ROA(5y)N/A
ROE(3y)18.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.02
Cap/Depr 22.24%
Cap/Sales 0.66%
Interest Coverage N/A
Cash Conversion 5.33%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 7.84
F-Score5
WACC6.81%
ROIC/WACCN/A
Cap/Depr(3y)24.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-155.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.98%
OCF growth 3YN/A
OCF growth 5YN/A

CTW CAYMAN-CL A / CTW Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CTW CAYMAN-CL A (CTW) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTW.


Can you provide the valuation status for CTW CAYMAN-CL A?

ChartMill assigns a valuation rating of 1 / 10 to CTW CAYMAN-CL A (CTW). This can be considered as Overvalued.


How profitable is CTW CAYMAN-CL A (CTW) stock?

CTW CAYMAN-CL A (CTW) has a profitability rating of 3 / 10.


What is the financial health of CTW CAYMAN-CL A (CTW) stock?

The financial health rating of CTW CAYMAN-CL A (CTW) is 5 / 10.